Alexa

Global Infertility Treatment Market - Emergence of Digital Innovations to Promote Growth | Technavio

Global Infertility Treatment Market - Emergence of Digital Innovations to Promote Growth | Technavio

LONDON--(BUSINESS WIRE)--Apr 30, 2018-- market research analysts forecast the to grow at a CAGR of more than 5% during the period 2018-2022, according to their latest report.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180430005811/en/

Technavio has published a new market research report on the global infertility treatment market from 2018-2022. (Graphic: Business Wire)

The emergence of digital innovations is one of the major trends being witnessed in the market. To run any clinic efficiently, a high patient footfall is necessary. This is invariably related to how effectively the clinics market their services. With the emergence of advanced technologies that carry out various types of ART procedures, the market is evolving, and the change is evident in the way fertility clinics are marketing their services. Biotechnology firms have entered the ART market and are concentrating on improving the consumers’ access to infertility treatment services. The emergence of personalized medicine specifically for infertility treatment in women is the biggest change visible in the market, and this is contributing to the increasing adoption.

This report is available at a USD 1,000 discount for a limited time only:

Save more with Technavio. Buy2 reports and get the third for FREE:

In this report, Technavio analysts highlight the increase in lifestyle-related diseases as a key factor contributing to the growth of the global market:

Increase in lifestyle-related diseases

A sedentary lifestyle is one of the key reasons for chronic conditions such as diabetes, obesity, and high blood pressure among people today. Lack of physical activity and sedentary lifestyles directly affects health and could precipitate health conditions. Lifestyle diseases such as diabetes, obesity, and high blood pressure are some of the potential high-risk factors that lead to infertility. The continuous increase in cases of chronic diseases has created concern among healthcare professionals across the globe.

Diabetes comes with an increased risk of developing several serious health issues. A constantly high blood glucose can lead to severe health conditions such as poor blood flow through the body, which can affect the sex life of both males and females. While diabetes in men causes erectile dysfunction because of reduced blood circulation, in women, it prevents the implantation of the embryo in the uterus, thereby leading to infertility. Diabetes is becoming one of the most serious health concerns among people.

According to a senior analyst at Technavio for , “According to a research, it has been established that it is difficult for a woman with high glucose levels to conceive because high glucose levels prevent the implantation of the embryo in the uterus. It can result in a miscarriage even before the pregnancy is realized. It has been found that diabetes increases the chances of miscarriage to about 45%. Even though the implantation occurs, complications stay throughout the pregnancy.”

Looking for more information on this market?

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Global infertility treatment market segmentation

This market research report segments the global market into the following applications (male infertility treatment and female infertility treatment) and key regions (the Americas, APAC, and EMEA). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.

Of the two major applications, the female infertility treatment segment held the largest market share in 2017, accounting for more than 89 % of the market. This application will dominate the market throughout the forecast period.

The Americas was the leading region for the global infertility treatment market in 2017, accounting for a market share of more than 48%. It was followed by EMEA and APAC respectively. APAC is expected to post significant growth during the forecast period when compared with the other regions.

Technavio supports Health for All campaign on this World Health Day with 20% savings on all reports in the category for the entire month.

About Technavio

is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at .

View source version on businesswire.com:https://www.businesswire.com/news/home/20180430005811/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

KEYWORD: EUROPE ASIA PACIFIC NORTH AMERICA SOUTH AMERICA AFRICA MIDDLE EAST

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY FITNESS & NUTRITION PHARMACEUTICAL PROFESSIONAL SERVICES OTHER PROFESSIONAL SERVICES RESEARCH SCIENCE

SOURCE: Technavio Research

Copyright Business Wire 2018.

PUB: 04/30/2018 10:18 AM/DISC: 04/30/2018 10:18 AM

http://www.businesswire.com/news/home/20180430005811/en